98 related articles for article (PubMed ID: 25892518)
21. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
Herzer K; Gerken G; Hofmann TG
World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
[TBL] [Abstract][Full Text] [Related]
23. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
24. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
25. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.
Leu JI; Crissey MA; Leu JP; Ciliberto G; Taub R
Mol Cell Biol; 2001 Jan; 21(2):414-24. PubMed ID: 11134330
[TBL] [Abstract][Full Text] [Related]
27. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
28. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
Wu WS; Xu ZX; Ran R; Meng F; Chang KS
Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
[TBL] [Abstract][Full Text] [Related]
29. Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein.
Sieben M; Herzer K; Zeidler M; Heinrichs V; Leuchs B; Schuler M; Cornelis JJ; Galle PR; Rommelaere J; Moehler M
World J Gastroenterol; 2008 Jun; 14(24):3819-28. PubMed ID: 18609705
[TBL] [Abstract][Full Text] [Related]
30. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.
Wu WS; Vallian S; Seto E; Yang WM; Edmondson D; Roth S; Chang KS
Mol Cell Biol; 2001 Apr; 21(7):2259-68. PubMed ID: 11259576
[TBL] [Abstract][Full Text] [Related]
31. Regulation of STAT3-mediated signaling by LMW-DSP2.
Sekine Y; Tsuji S; Ikeda O; Sato N; Aoki N; Aoyama K; Sugiyama K; Matsuda T
Oncogene; 2006 Sep; 25(42):5801-6. PubMed ID: 16636663
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
33. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
[TBL] [Abstract][Full Text] [Related]
34. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression.
Sun X; Sui Q; Zhang C; Tian Z; Zhang J
Mol Cancer Ther; 2013 Dec; 12(12):2885-96. PubMed ID: 24107450
[TBL] [Abstract][Full Text] [Related]
35. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
36. Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
Ploeger C; Waldburger N; Fraas A; Goeppert B; Pusch S; Breuhahn K; Wang XW; Schirmacher P; Roessler S
Hepatology; 2016 Sep; 64(3):828-42. PubMed ID: 27311882
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
Chan JY; Chin W; Liew CT; Chang KS; Johnson PJ
Eur J Cancer; 1998 Jun; 34(7):1015-22. PubMed ID: 9849449
[TBL] [Abstract][Full Text] [Related]
38. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
Zhang J; Li Z; Liu L; Wang Q; Li S; Chen D; Hu Z; Yu T; Ding J; Li J; Yao M; Huang S; Zhao Y; He X
Hepatology; 2018 Jan; 67(1):171-187. PubMed ID: 28746790
[TBL] [Abstract][Full Text] [Related]
40. Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma.
Beyazit Y; Kekilli M; Kurt M; Sayilir A; Tas A; Onal IK
Aliment Pharmacol Ther; 2010 Jul; 32(2):304-5. PubMed ID: 20636625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
